Signaturefd LLC raised its position in CVS Health Corporation (NYSE:CVS) by 14.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,933 shares of the pharmacy operator’s stock after buying an additional 1,024 shares during the period. Signaturefd LLC’s holdings in CVS Health Corporation were worth $623,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Naples Global Advisors LLC acquired a new position in shares of CVS Health Corporation during the first quarter worth about $452,000. Regent Investment Management LLC raised its position in shares of CVS Health Corporation by 0.6% in the first quarter. Regent Investment Management LLC now owns 66,818 shares of the pharmacy operator’s stock worth $5,245,000 after buying an additional 429 shares during the period. Thompson Rubinstein Investment Management Inc. OR raised its position in shares of CVS Health Corporation by 8.7% in the first quarter. Thompson Rubinstein Investment Management Inc. OR now owns 39,646 shares of the pharmacy operator’s stock worth $3,112,000 after buying an additional 3,159 shares during the period. Candriam Luxembourg S.C.A. raised its position in shares of CVS Health Corporation by 17.9% in the first quarter. Candriam Luxembourg S.C.A. now owns 92,139 shares of the pharmacy operator’s stock worth $7,233,000 after buying an additional 14,012 shares during the period. Finally, Koshinski Asset Management Inc. raised its position in shares of CVS Health Corporation by 83.3% in the first quarter. Koshinski Asset Management Inc. now owns 21,694 shares of the pharmacy operator’s stock worth $1,703,000 after buying an additional 9,858 shares during the period. Institutional investors and hedge funds own 81.92% of the company’s stock.

CVS Health Corporation (NYSE CVS) traded up 0.34% during midday trading on Friday, reaching $79.41. The company’s stock had a trading volume of 2,985,502 shares. The company has a market capitalization of $80.73 billion, a price-to-earnings ratio of 15.82 and a beta of 0.91. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $98.44. The company’s 50-day moving average price is $78.83 and its 200-day moving average price is $78.96.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The company had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. During the same quarter in the prior year, the business posted $1.32 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, analysts predict that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 3rd. Stockholders of record on Monday, July 24th were paid a $0.50 dividend. The ex-dividend date was Thursday, July 20th. This represents a $2.00 annualized dividend and a dividend yield of 2.52%. CVS Health Corporation’s payout ratio is 39.92%.

TRADEMARK VIOLATION NOTICE: This report was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this report on another site, it was stolen and republished in violation of US & international trademark & copyright law. The original version of this report can be accessed at https://theolympiareport.com/2017/08/12/signaturefd-llc-boosts-stake-in-cvs-health-corporation-cvs.html.

A number of equities analysts have recently issued reports on CVS shares. Evercore ISI restated an “outperform” rating and set a $88.00 target price (up from $87.00) on shares of CVS Health Corporation in a research report on Wednesday, May 3rd. Vetr upgraded shares of CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $85.96 target price on the stock in a research report on Wednesday, May 17th. ValuEngine lowered shares of CVS Health Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Tigress Financial started coverage on shares of CVS Health Corporation in a research report on Thursday, April 27th. They set a “buy” rating on the stock. Finally, Guggenheim restated a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 3rd. Eight analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. CVS Health Corporation currently has an average rating of “Buy” and a consensus price target of $91.27.

In other news, EVP Helena Foulkes sold 20,333 shares of the stock in a transaction on Monday, June 26th. The stock was sold at an average price of $80.00, for a total value of $1,626,640.00. Following the completion of the transaction, the executive vice president now owns 59,301 shares of the company’s stock, valued at $4,744,080. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO David M. Denton sold 230,510 shares of the stock in a transaction on Monday, June 12th. The stock was sold at an average price of $80.00, for a total value of $18,440,800.00. Following the completion of the transaction, the chief financial officer now directly owns 176,983 shares of the company’s stock, valued at approximately $14,158,640. The disclosure for this sale can be found here. In the last three months, insiders sold 271,175 shares of company stock valued at $21,632,597. Company insiders own 0.61% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.